We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEJO
11876
CALL
DELISTED
Wejo Group Limited Common Shares
WEJO
$47K ﹤0.01%
39,300
+18,300
+87% +$42.8K
NH
11877
DELISTED
NantHealth, Inc
NH
$47K ﹤0.01%
+7,480
New +$69.8K
GFX.WS
11878
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$47K ﹤0.01%
502,770
-396,689
-44% -$67.1K
AFMD
11879
PUT
DELISTED
Affimed
AFMD
$46K ﹤0.01%
1,650
-1,490
-47% -$51K
AQST icon
11880
Aquestive Therapeutics
AQST
$533M
$46K ﹤0.01%
71,995
+35,205
+96% +$46.8K
BKD icon
11881
CALL
Brookdale Senior Living
BKD
$3.02B
$46K ﹤0.01%
10,200
-11,700
-53% -$69.1K
CCLD icon
11882
CareCloud
CCLD
$110M
$46K ﹤0.01%
13,346
+3,321
+33% +$13.2K
DTST icon
11883
Data Storage Corp
DTST
$7.15M
$46K ﹤0.01%
+18,705
New +$53.5K
DXLG icon
11884
CALL
Destination XL Group
DXLG
$35.4M
$46K ﹤0.01%
13,700
-15,800
-54% -$71.2K
GOCO
11885
PUT
DELISTED
GoHealth
GOCO
$46K ﹤0.01%
5,173
-407
-7% -$4.73K
GROW icon
11886
PUT
US Global Investors
GROW
$39.4M
$46K ﹤0.01%
10,500
-7,000
-40% -$34K
GWH icon
11887
CALL
ESS Tech
GWH
$20.4M
$46K ﹤0.01%
1,080
-4,027
-79% -$283K
INSG icon
11888
PUT
Inseego
INSG
$77M
$46K ﹤0.01%
2,430
-2,000
-45% -$51K
MNTS icon
11889
PUT
Momentus
MNTS
$91.2M
$46K ﹤0.01%
2
-1
-33% -$36.5K
SOPA
11890
DELISTED
Society Pass
SOPA
$46K ﹤0.01%
+1,582
New +$52K
GPUS
11891
Hyperscale Data Inc
GPUS
$43.2M
$46K ﹤0.01%
1
-2
-67% -$124K
GPUS
11892
PUT
Hyperscale Data Inc
GPUS
$43.2M
$46K ﹤0.01%
1
-1
-50% -$61.9K
CLYM
11893
Climb Bio
CLYM
$938M
$46K ﹤0.01%
+15,211
New +$72K
OIG
11894
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$46K ﹤0.01%
1,823
-150
-8% -$6.65K
HYRE
11895
CALL
DELISTED
HyreCar Inc. Common Stock
HYRE
$46K ﹤0.01%
75,300
+20,500
+37% +$26.3K
LBPS
11896
DELISTED
4D Pharma PLC
LBPS
$46K ﹤0.01%
28,166
-3,372
-11% -$11.5K
ADN
11897
PUT
DELISTED
Advent Technologies
ADN
$45K ﹤0.01%
593
+83
+16% +$5.01K
BDSX icon
11898
Biodesix
BDSX
$253M
$45K ﹤0.01%
1,380
+499
+57% +$16.2K
DXLG icon
11899
PUT
Destination XL Group
DXLG
$35.4M
$45K ﹤0.01%
13,200
-16,200
-55% -$73K
GORO icon
11900
PUT
Goldgroup Mining
GORO
$207M
$45K ﹤0.01%
27,400
-32,900
-55% -$64.6K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.